Synthesis of new aliphatic derivatives of 5-acetyl-3,4-dihydropyrimidin-2(1H)-ones(thiones) and in silico analysis of the bioactivity of the obtained compounds

Authors

  • Anton A. Levdansky Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus
  • Iryna V. Mineyeva Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus; Research Institute for Physical Chemical Problems, Belarusian State University, 14 Lieningradskaja Street, Minsk 220006, Belarus

Keywords:

multicomponent Biginelli reaction, 5-acetyl-3,4-dihydropyrimidin-2(1H)-ones(thiones), aliphatic aldehydes, 1-(2-oxoethyl)cyclopropyl acetate, europium(III) chloride hexahydrate, PerMM electronic platform, PassOnline electronic platform, in silico analysis
Supporting Agencies
The research was supported by the Ministry of Education of the Republic of Belarus (assignment 2.2.9 of the state programme of scientific research «Chemical processes, reagents and technologies, bioregulators and bioorgchemistry», state registration No. 20240340).

Abstract

An effective method for obtaining 5-acetyl-3,4-dihydropyrimidin-2(1H)-ones(thiones) based on aliphatic aldehydes, including β-hydroxycyclopropane, using europium(III) chloride hexahydrate as a catalyst for the multicomponent Biginelli reaction has been developed. In silico calculation of the biological properties of the obtained compounds using the PassOnline electronic platform showed a high probability of biotransformation of the studied substances along the natural biochemical pathway when exposed to cytochrome P450 of isoform 2J2 (CYP2J2), and also that all the studied compounds can theoretically act as membrane integrity agonists, stimulators of leukopoiesis and exhibit cytotoxic properties relative to many cancer cells. Modelling of permeability through the phospholipid bilayer using the PerMM electronic platform of 5-acetyl-3,4-dihydropyrimidin-2(1H)-ones(thiones) showed that all the studied compounds are capable of passively penetrating through model cell membranes and participating in intracellular regulation processes.

Author Biographies

  • Anton A. Levdansky, Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus

    master’s degree student at the department of organic chemistry, faculty of chemistry

  • Iryna V. Mineyeva, Belarusian State University, 4 Niezaliezhnasci Avenue, Minsk 220030, Belarus; Research Institute for Physical Chemical Problems, Belarusian State University, 14 Lieningradskaja Street, Minsk 220006, Belarus

    doctor of science (chemistry); professor at the department of organic chemistry, faculty of chemistry, Belarusian State University, and head of the fine organic synthesis sector, Research Institute for Physical Chemical Problems, Belarusian State University

References

  1. Wan J-P, Liu Y. Synthesis of dihydropyrimidinones and thiones by multicomponent reactions: strategies beyond the classical Biginelli reaction. Synthesis. 2010;42(23):3943–3953. DOI: 10.1055/s-0030-1258290.
  2. Sandhu SS, Sandhu JS. Past, present and future of the Biginelli reaction: a critical perspective. Arkivoc. 2012;1:66–133. DOI: 10.3998/ark.5550190.0013.103.
  3. Panda SS, Khanna P, Khanna L. Biginelli reaction: a green perspective. Current Organic Chemistry. 2012;16(4):507–520. DOI: 10.2174/138527212799499859.
  4. Nagarajaiah H, Mukhopadhyay A, Moorthy JN. Biginelli reaction: an overview. Tetrahedron Letters. 2016;57(47):5135–5149. DOI: 10.1016/j.tetlet.2016.09.047.
  5. Kaur R, Chaudhary S, Kumar K, Gupta MK, Rawal RK. Recent synthetic and medicinal perspectives of dihydropyrimidinones: а review. European Journal of Medicinal Chemistry. 2017;132:108–134. DOI: 10.1016/j.ejmech.2017.03.025.
  6. Chandravarkar A, Aneeja T, Anilkumar G. Advances in Biginelli reaction: а comprehensive review. Journal of Heterocyclic Chemistry. 2024;61(1):5–28. DOI: 10.1002/jhet.4742.
  7. Narkhede HI, Nevagi RJ, Kumbhare M, Kaur P. Synthesis and in vitro screening of novel dihydropyrimidine derivatives as potential calcium channel blockers. Der Pharma Chemica. 2014;6(2):221–227.
  8. Singh K, Arora D, Singh K, Singh S. Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects. Mini-Reviews in Medicinal Chemistry. 2009;9(1):95–106. DOI: 10.2174/138955709787001686.
  9. Lauro G, Strocchia M, Terracciano S, Bruno I, Fischer K, Pergola C, et al. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1). European Journal of Medicinal Chemistry. 2014;80:407–415. DOI: 10.1016/j.ejmech.2014.04.061.
  10. Zhu Y, Pan Y, Huang S. Trimethylsilyl chloride: a facile and efficient reagent for one-pot synthesis of 3,4-dihydropyrimidin-2(1H )-ones. Synthetic Communications. 2004;34(17):3167–3174. DOI: 10.1081/SCC-200028607.
  11. Liu J, Wu F, Chen L, Hu J, Zhao L, Chen C, et al. Evaluation of dihydropyrimidin-(2H )-one analogues and rhodanine derivatives as tyrosinase inhibitors. Bioorganic and Medicinal Chemistry Letters. 2011;21(8):2376–2379. DOI: 10.1016/j.bmcl.2011.02.076.
  12. Wang L, Zhou M, Chen Q, He M-Y. Facile Biginelli-type reactions catalysed by super acidic ionic liquid under solvent-free conditions. Journal of Chemical Research. 2012;36(12):712–714. DOI: 10.3184/174751912X13518654161237.
  13. Kolosov MA, Kulyk OG, Beloborodov DA, Orlov VD. A simple and efficient one-pot synthesis of 4-alkyl-3,4-dihydropyrimidin-2(1H )-ones. Journal of Chemical Research. 2013;37(2):115–118. DOI: 10.3184/174751913X13573126386.
  14. Shutalev AD, Fesenko AA, Strel’tsova ED. A general approach to 4-unsubstituted and 4-alkyl-substituted 5-acyl-1,2,3,4-tetrahydropyrimidine-2-thiones(ones) via α-(thio)ureidoalkylation of 1,3-diketones or β-oxoesters. Chemistry of Heterocyclic Compounds. 2022;58(12):695–711. DOI: 10.1007/s10593-023-03146-6.
  15. Salaün J, Baird MS. Biologically active cyclopropanes and cyclopropenes. Current Medicinal Chemistry. 1995;2(1):511–542. DOI: 10.2174/0929867302666220216234752.
  16. Salaün J. Cyclopropane derivatives and their diverse biological activities. In: Meijere A, editor. Small ring compounds in organic synthesis VI. Berlin: Springer; 2000. p. 2–57 (Topics in current chemistry; volume 207). DOI: 10.1007/3-540-48255-5_1.
  17. Lamberth C. Small ring chemistry in crop protection. Tetrahedron. 2019;75(33):4365–4383. DOI: 10.1016/j.tet.2019.06.043.
  18. Ganesh V, Chandrasekaran S. Recent advances in the synthesis and reactivity of vinylcyclopropanes. Synthesis. 2016;48(24):4347–4380. DOI: 10.1055/s-0035-1562530.
  19. Минеева ИВ, Фалетров ЯВ, Старовойтова ВА, Шкуматов ВМ. Синтез новых 1,4-дигидропиридинов: оптимизация условий синтеза и in silico анализ биоактивности полученных соединений. Журнал органической химии. 2022;58(3):248–263. DOI: 10.31857/S051474922203003X.
  20. Lomize AL, Hage JM, Schnitzer K, Golobokov K, LaFaive MB, Forsyth AC, et al. PerMM: a web tool and database for analysis of passive membrane permeability and translocation pathways of bioactive molecules. Journal of Chemical Information and Modeling. 2019;59(7):3094–3099. DOI: 10.1021/acs.jcim.9b00225.

Downloads

Published

2025-05-20

How to Cite

Synthesis of new aliphatic derivatives of 5-acetyl-3,4-dihydropyrimidin-2(1H)-ones(thiones) and in silico analysis of the bioactivity of the obtained compounds. (2025). Journal of the Belarusian State University. Chemistry, 1, 3-12. https://journals.bsu.by/index.php/chemistry/article/view/6662